The templates that comprise the Radiopharmaceutical Radiation Dose SR are interconnected as in Figure A-17.
This template defines a container (the root) with subsidiary content items, each of which corresponds to a single Radiopharmaceutical Administration Dose event entry. There is a defined recording observer (the system and/or person responsible for recording the assay of the radiopharmaceutical, and the person administered the radiopharmaceutical). Multiple Radiopharmaceutical Radiation Dose objects may be created for one study. Radiopharmaceutical Start DateTime in TID 10022 “Radiopharmaceutical Administration Event Data” will convey the order of administrations.
Extensible
Significant
Yes
Table TID 10021. Radiopharmaceutical Radiation Dose
|
NL |
Rel with Parent |
VT |
Concept Name |
VM |
Req Type |
Condition |
Value Set Constraint |
|
|---|---|---|---|---|---|---|---|---|
|
1 |
CONTAINER |
EV (113500, DCM, "Radiopharmaceutical Radiation Dose Report") |
1 |
M |
||||
|
2 |
> |
HAS CONCEPT MOD |
CODE |
EV (G-C2D0, SRT, "Associated Procedure") |
1 |
M |
||
|
3 |
>> |
HAS CONCEPT MOD |
CODE |
EV (G-C0E8, SRT, "Has Intent") |
1 |
M |
||
|
4 |
> |
CONTAINS |
INCLUDE |
1 |
M |
|||
|
5 |
> |
CONTAINS |
INCLUDE |
DTID 10024 “Radiopharmaceutical Administration Patient Characteristics” |
1 |
U |
||
|
6 |
> |
CONTAINS |
TEXT |
1 |
U |
Content Item Descriptions
|
Row 2 |
The associated procedure is the procedure performed, or if no procedure was performed the procedure that was ordered. |
The Radiopharmaceutical Administration Event conveys the dose and assay and time information of a single radiopharmaceutical event. A Radiopharmaceutical Administration event is one radioactive pharmaceutical administered to a patient.
Extensible
Significant
Table TID 10022. Radiopharmaceutical Administration Event Data
|
NL |
Rel with Parent |
VT |
Concept Name |
VM |
Req Type |
Condition |
Value Set Constraint |
|
|---|---|---|---|---|---|---|---|---|
|
1 |
CONTAINER |
1 |
M |
|||||
|
2 |
> |
CONTAINS |
CODE |
EV (F-61FDB, SRT, "Radiopharmaceutical agent") |
1 |
M |
||
|
3 |
>> |
HAS PROPERTIES |
CODE |
EV (C-10072, SRT, "Radionuclide") |
1 |
M |
||
|
4 |
>> |
HAS PROPERTIES |
NUM |
EV (R-42806, SRT, "Radionuclide Half Life") |
1 |
M |
UNITS = EV (s, UCUM, "seconds") |
|
|
5 |
> |
CONTAINS |
NUM |
1 |
U |
UNITS = EV (Bq/mmol, UCUM, "Bq/mmol") |
||
|
6 |
> |
CONTAINS |
UIDREF |
EV (113503, DCM, "Radiopharmaceutical Administration Event UID") |
1 |
M |
||
|
7 |
> |
CONTAINS |
CODE |
1-n |
U |
|||
|
8 |
> |
CONTAINS |
NUM |
1 |
U |
UNITS = EV(%, UCUM, "percent") |
||
|
9 |
> |
CONTAINS |
DATETIME |
1 |
M |
|||
|
10 |
> |
CONTAINS |
DATETIME |
1 |
U |
|||
|
11 |
> |
CONTAINS |
NUM |
1 |
M |
UNITS = EV (MBq, UCUM, "MBq") |
||
|
12 |
> |
CONTAINS |
NUM |
1 |
U |
UNITS = EV (cm3, UCUM, "cm3") |
||
|
13 |
> |
CONTAINS |
NUM |
1 |
U |
UNITS = EV (MBq, UCUM, "MBq") |
||
|
14 |
>> |
HAS OBS CONTEXT |
CODE |
1 |
U |
|||
|
15 |
>> |
HAS OBS CONTEXT |
INCLUDE |
1-n |
U |
|||
|
16 |
> |
CONTAINS |
NUM |
1 |
U |
UNITS = EV (MBq, UCUM, "MBq") |
||
|
17 |
>> |
HAS OBS CONTEXT |
CODE |
1 |
U |
|||
|
18 |
>> |
HAS OBS CONTEXT |
INCLUDE |
1-n |
U |
|||
|
19 |
> |
CONTAINS |
INCLUDE |
1-n |
U |
|||
|
20 |
> |
CONTAINS |
CODE |
EV (G-C340, SRT, "Route of administration") |
1 |
M |
||
|
21 |
>> |
HAS PROPERTIES |
CODE |
EV (G-C581, SRT, "Site of") |
1 |
MC |
IF Row 22 equals (G-D101, SRT, "Intravenous route") or (G-D103, SRT, "Intramuscular route") |
|
|
22 |
>>> |
HAS CONCEPT MOD |
CODE |
EV (G-C171, SRT, "Laterality") |
1 |
MC |
IF Row 23 has laterality |
|
|
23 |
> |
HAS OBS CONTEXT |
INCLUDE |
1-n |
M |
$PersonProcedureRole = EV (113851, DCM, "Irradiation Administering") |
||
|
24 |
> |
CONTAINS |
CODE |
1-n |
U |
|||
|
25 |
> |
CONTAINS |
CODE |
1-n |
U |
|||
|
26 |
> |
CONTAINS |
TEXT |
1 |
U |
|||
|
27 |
> |
CONTAINS |
TEXT |
EV (113511, DCM, "Radiopharmaceutical Dispense Unit Identifier") |
1 |
U |
||
|
28 |
>> |
CONTAINS |
TEXT |
1-n |
U |
|||
|
29 |
>> |
CONTAINS |
TEXT |
1-n |
U |
|||
|
30 |
>> |
CONTAINS |
TEXT |
1-n |
U |
|||
|
31 |
> |
CONTAINS |
TEXT |
1 |
U |
|||
|
32 |
> |
CONTAINS |
TEXT |
1 |
U |
Content Item Descriptions
|
Row 4 |
The value of Half-life that was used for computing the decay of the administered radiopharmaceutical. It is not intended for use by the receiver for any further computation. |
|
Row 5 |
Activity per unit mass of the radiopharmaceutical at Radiopharmaceutical Start Time |
|
Row 6 |
Unique identification of a single radiopharmaceutical administration event. |
|
Row 8 |
The estimated percentage of administered activity lost at the injection site. The estimation includes extravasation, paravenous administration and leakage at the injection site. |
|
Row 9 |
The time the radiopharmaceutical was administered to the patient for imaging purposes. |
|
Row 11 |
Total amount of radioactivity administered to the patient at Radiopharmaceutical Start Time. It is a computed field from the TID 10022 Pre-Administration Measured Activity Row 13, TID 10022 Post-Administration Measured Activity Row 17, Radionuclide Half Life Row 4 and Radiopharmaceutical Start Time Row 9. Does not include estimated extravasation activity. |
|
Rows 13, 16 |
Observation DateTime (0040,A032) shall be used to record when the measurement was taken. |
|
Row 23 |
Identifies the person administering the product. |
|
Row 24 |
The billing codes for the preparation and administration of the radiopharmaceutical. It does not include performance and interpretation of the imaging. |
|
Row 25 |
Registered drug establishment code for the product. A coding scheme example is NDC, WHO-DDE or RxNorm. Multiple entries can be used for equivalent drug product codes. |
|
Row 27 |
The human readable identification of the specific radiopharmaceutical quantity (dose) administered to the patient. |
|
Row 28 |
Identifies the vial, batch or lot number from which the individual radiopharmaceutical quantity (dose) was produced. Row 27 the Radiopharmaceutical Identifier records the identification for each individual dose. |
|
Row 29 |
Identifies the lot or unit serial number for the reagent component for the radiopharmaceutical identified in row 27. |
|
Row 30 |
Identifies the lot or unit serial number for the radionuclide component for the radiopharmaceutical identified in row 27. |
This template conveys the information about the dose to a single organ.
Extensible
Significant
Table TID 10023. Organ Dose
|
NL |
Rel with Parent |
VT |
Concept Name |
VM |
Req Type |
Condition |
Value Set Constraint |
|
|---|---|---|---|---|---|---|---|---|
|
1 |
CONTAINER |
1 |
M |
|||||
|
2 |
> |
HAS CONCEPT MOD |
CODE |
EV (G-C0E3, SRT, "Finding Site") |
1 |
M |
||
|
3 |
> |
HAS CONCEPT MOD |
CODE |
EV (G-C171, SRT, "Laterality") |
1 |
MC |
IFF anatomy has laterality |
|
|
4 |
> |
CONTAINS |
NUM |
EV (G-D701, SRT, "Mass") |
1 |
U |
UNITS = EV (g, UCUM, "grams") |
|
|
5 |
>> |
HAS CONCEPT MOD |
TEXT |
EV (G-C036, SRT, "Measurement Method") |
1 |
M |
||
|
6 |
> |
CONTAINS |
NUM |
1 |
M |
UNITS = EV (mGy, UCUM, "mGy") |
||
|
7 |
>> |
HAS PROPERTIES |
CODE |
1 |
MC |
XOR Row 8 |
BCID 10040 “Radiopharmaceutical Organ Dose Reference Authority” |
|
|
8 |
>> |
HAS PROPERTIES |
TEXT |
1 |
MC |
XOR Row 7 |
Content Item Descriptions
|
Row 3 |
For paired organs,use (G-A102, SRT, "Right and Left") to report the estimated absorbed dose for both organs. |
|
Row 4 |
The estimated mass of organ in grams used when calculating the organ dose. |
|
Row 5 |
Method used to obtain the estimate. This could include a method that does not involve performing a measurement (e.g., Standard Organ Mass Tables). |
|
Row 6 |
Organ dose (in units of mGy). Organ is specified by row 2. |
This template describes the characteristics of the patient that are specific to the current clinical presentation (visit). The characteristics noted may affect the activity received, and how dose is calculated for the patient. Patient Characteristic concepts in this template, which may replicate attributes in the Patient Study Module, are included here as possible targets of by-reference relationships from other content items in the SR tree.
Extensible
Significant
Table >TID 10024. Radiopharmaceutical Administration Patient Characteristics
|
NL |
Rel with Parent |
VT |
Concept Name |
VM |
Req Type |
Condition |
Value Set Constraint |
|
|---|---|---|---|---|---|---|---|---|
|
1 |
CONTAINER |
|||||||
|
2 |
> |
CONTAINS |
CODE |
1-n |
U |
|||
|
3 |
> |
CONTAINS |
NUM |
1 |
U |
UNITS = DCID 7456 “Units of Measure for Age” |
||
|
4 |
> |
CONTAINS |
CODE |
1 |
U |
|||
|
5 |
> |
CONTAINS |
NUM |
1 |
U |
UNITS = EV (cm, UCUM, "cm") |
||
|
6 |
> |
CONTAINS |
NUM |
1 |
U |
UNITS = EV (kg, UCUM, "kg"). |
||
|
7 |
> |
CONTAINS |
NUM |
1 |
U |
UNITS = EV (m2, UCUM, "m^2") |
||
|
8 |
>> |
INFERRED FROM |
CODE |
1 |
U |
|||
|
9 |
> |
CONTAINS |
NUM |
EV (F-01860, SRT, "Body Mass Index") |
1 |
U |
UNITS = EV (kg/m2, UCUM, "kg/m^2") |
|
|
10 |
>> |
INFERRED FROM |
CODE |
1 |
U |
|||
|
11 |
> |
CONTAINS |
NUM |
1 |
U |
UNITS = EV ("mmol/l", UCUM, "mmol/l") |
||
|
12 |
> |
CONTAINS |
NUM |
1 |
U |
UNITS = DT (h, UCUM, "hours") |
||
|
13 |
> |
CONTAINS |
NUM |
1 |
U |
UNITS = DT (ml, UCUM, "ml") |
||
|
14 |
> |
CONTAINS |
TEXT |
1 |
U |
|||
|
15 |
> |
CONTAINS |
NUM |
1 |
U |
UNITS = DT (mg/dl, UCUM, "mg/dl") |
||
|
16 |
> |
CONTAINS |
NUM |
EV (F-70210, SRT, "Glomerular Filtration Rate") |
1-n |
U |
UNITS = DT (ml/min{1.73_m2}, UCUM, "ml/min/1.73m2") |
|
|
17 |
>> |
HAS CONCEPT MOD |
CODE |
EV (G-C036, SRT, "Measurement Method") |
1 |
U |
||
|
18 |
>> |
HAS CONCEPT MOD |
CODE |
1 |
M |
Content Item Descriptions
|
Row 3 |
Defaults to value of Patient's Age (0010,1010) in Patient Study Module |
|
Row 5 |
Patient height may differ from Patient's Size (0010,1020). Row 4 is the height value used for any height based protocols. Observation DateTime (0040,A032) may be used to record when the measurement was taken. |
|
Row 6 |
Patient weight may differ from Patient's Weight (0010,1030). Row 5 is the weight value used for any weight based protocols. Observation DateTime (0040,A032) shall be used to record when the measurement was taken. |
|
Row 11 |
Patient's Blood Glucose level. Observation DateTime (0040,A032) shall be used to record when the measurement was taken. |
|
Row 15 |
Serum Creatinine level. Observation DateTime (0040,A032) shall be used to record when the measurement was taken. |
|
Row 16 |
Glomerular Filtration Rate Observation DateTime (0040,A032) shall be used to record when the measurement was taken. The formatting of the UCUM units is aligned with LOINC. See http://unitsofmeasure.org/trac/ticket/98 |